Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$651K Sell
6,393
-61
-0.9% -$6.84K ﹤0.01% 2471
2026
Q1
$701K Buy
6,454
+5,464
+552% +$625K ﹤0.01% 2459
2025
Q4
$90.6K Buy
+990
New +$89.1K ﹤0.01% 2540
2025
Q3
Sell
-760,211
Closed -$56.4M 2343
2025
Q2
$56.4M Buy
760,211
+155,370
+26% +$8.29M 0.01% 666
2025
Q1
$24.9M Buy
604,841
+64,512
+12% +$3.04M 0.01% 871
2024
Q4
$27.8M Sell
540,329
-166,426
-24% -$9.07M 0.01% 828
2024
Q3
$33.8M Buy
706,755
+70,454
+11% +$3.07M 0.01% 773
2024
Q2
$31.3M Buy
+636,301
New +$32.3M 0.01% 735
2019
Q4
Sell
-46
Closed -$437 2575
2019
Q3
$437 Hold
46
﹤0.01% 2883
2019
Q2
$494 Sell
46
-115
-71% -$1.24K ﹤0.01% 2853
2019
Q1
$1.9K Sell
161
-60
-27% -$721 ﹤0.01% 2757
2018
Q4
$2.51K Hold
221
﹤0.01% 2717
2018
Q3
$2.52K Hold
221
﹤0.01% 2729
2018
Q2
$2.49K Buy
221
+144
+187% +$1.57K ﹤0.01% 2740
2018
Q1
$700 Buy
+77
New +$713 ﹤0.01% 2649

Other funds holding CCJ

UBS AM's CCJ Position: Q2 2026 in Review

UBS AM reduced its Cameco (CCJ) stake by 0.95% in Q2 2026, selling an estimated $6.84K and leaving 6,393 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #2471.

UBS AM first reported a position in CCJ in Q1 2018 and has held it in 15 quarters since. The position peaked at $56.4M in Q2 2025. 1,033 funds tracked by Wall St. Rank hold CCJ as of Q2 2026.

  • UBS AM held 6,393 shares of Cameco worth $651K as of Q2 2026.
  • UBS AM sold 61 Cameco shares in Q2 2026, an estimated $6.84K.
  • Cameco made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2471 holding.
  • UBS AM first reported a position in Cameco in Q1 2018 and has held it in 15 quarters since.
  • UBS AM's Cameco position peaked at $56.4M in Q2 2025.
  • 1,033 funds tracked by Wall St. Rank held Cameco as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.